Hält derzeit Positionen bei Ardelyx Inc, Epizyme Inc, Mersana Therapeutics Inc and Adaptimmune Therapeutics PLC
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | Ardelyx Inc | 1. März 2014 - |
Independent Chairman of the Board | Epizyme Inc | 1. April 2016 - |
Independent Chairman of the Board | Mersana Therapeutics Inc | 1. Januar 2017 - |
Non-Executive Independent Chairman of the Board | Adaptimmune Therapeutics PLC | 1. Januar 2017 - |
Independent Chairman of the Board | TESARO Inc | 1. Juli 2011 - 22. Januar 2019 |
Chairman of the Board | Mersana Therapeutics Inc | 1. November 2013 - 1. Januar 2017 |
Non-Executive Vice Chairman of the Board | Adaptimmune Therapeutics PLC | 24. Mai 2016 - 1. Januar 2017 |
Non-Executive Independent Director | Adaptimmune Therapeutics PLC | 1. September 2014 - 24. Mai 2016 |
Independent Director | Epizyme Inc | 1. Dezember 2009 - 1. April 2016 |
Director | Ardelyx Inc | 1. März 2009 - 1. März 2014 |
Chairman of the Board | Mersana Therapeutics Inc | 1. Juli 2012 - 1. November 2013 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2022-11-17 | 2022-11-17 |
Ardelyx Inc
(ARDX)
|
K Kauf |
567.000
+94.5%
1,761.000.642 USD |
567.000 +94.5% | 1,76 | 1.000.642 USD | |
2022-02-23 | 2022-02-23 |
Imara Inc
(IMRA)
|
K Kauf |
35.257
+18.2%
1,4651.475 USD |
35.257 +18.2% | 1,46 | 51.475 USD | |
2022-02-23 | 2022-02-22 |
Imara Inc
(IMRA)
|
K Kauf |
65.817
+51.4%
1,56102.675 USD |
65.817 +51.4% | 1,56 | 102.675 USD | |
2022-02-23 | 2022-02-18 |
Imara Inc
(IMRA)
|
K Kauf |
50.398
+64.8%
1,3065.517 USD |
50.398 +64.8% | 1,30 | 65.517 USD | |
2022-02-17 | 2022-02-17 |
Imara Inc
(IMRA)
|
K Kauf |
14.595
+23.1%
1,1717.076 USD |
14.595 +23.1% | 1,17 | 17.076 USD | |
2022-02-17 | 2022-02-16 |
Imara Inc
(IMRA)
|
K Kauf |
11.779
+22.9%
1,2014.135 USD |
11.779 +22.9% | 1,20 | 14.135 USD | |
2022-02-17 | 2022-02-15 |
Imara Inc
(IMRA)
|
K Kauf |
19.552
+61.4%
1,2023.462 USD |
19.552 +61.4% | 1,20 | 23.462 USD | |
2022-02-14 | 2022-02-14 |
Imara Inc
(IMRA)
|
K Kauf |
8.500
+36.4%
1,1810.030 USD |
8.500 +36.4% | 1,18 | 10.030 USD | |
2022-02-14 | 2022-02-11 |
Imara Inc
(IMRA)
|
K Kauf |
14.573
+166.5%
1,2317.925 USD |
14.573 +166.5% | 1,23 | 17.925 USD | |
2022-02-14 | 2022-02-10 |
Imara Inc
(IMRA)
|
K Kauf |
8.753
+inf%
1,2911.291 USD |
8.753 +inf% | 1,29 | 11.291 USD | |
2021-03-29 | 2021-03-26 |
Epizyme Inc
(EPZM)
|
K Kauf |
217
+0.1%
7,801.693 USD |
217 +0.1% | 7,80 | 1.693 USD | |
2021-03-29 | 2021-03-26 |
Epizyme Inc
(EPZM)
|
K Kauf |
34.269
+29.4%
7,97273.124 USD |
34.269 +29.4% | 7,97 | 273.124 USD | |
2021-03-29 | 2021-03-25 |
Epizyme Inc
(EPZM)
|
K Kauf |
28.231
+32.0%
7,98225.283 USD |
28.231 +32.0% | 7,98 | 225.283 USD | |
2020-12-10 | 2020-12-10 |
Ardelyx Inc
(ARDX)
|
K Kauf |
170.000
+68.7%
5,891.000.841 USD |
170.000 +68.7% | 5,89 | 1.000.841 USD | |
2020-06-26 | 2020-06-26 |
Epizyme Inc
(EPZM)
|
K Kauf |
62.019
+301.3%
16,03994.165 USD |
62.019 +301.3% | 16,03 | 994.165 USD | |
2020-06-26 | 2020-06-25 |
Ardelyx Inc
(ARDX)
|
K Kauf |
68.373
+38.2%
6,96476.040 USD |
68.373 +38.2% | 6,96 | 476.040 USD | |
2020-06-26 | 2020-06-24 |
Ardelyx Inc
(ARDX)
|
K Kauf |
72.598
+68.3%
6,75489.862 USD |
72.598 +68.3% | 6,75 | 489.862 USD | |
2020-06-24 | 2020-06-22 |
Ardelyx Inc
(ARDX)
|
K Kauf |
4.673
+4.6%
6,7531.525 USD |
4.673 +4.6% | 6,75 | 31.525 USD | |
2020-04-09 | 2020-04-07 |
Mersana Therapeutics Inc
(MRSN)
|
K Kauf |
538.599
+inf%
5,593.010.768 USD |
538.599 +inf% | 5,59 | 3.010.768 USD | |
2020-01-28 | 2020-01-24 |
Adaptimmune Therapeutics PLC
(ADAP)
|
K Kauf |
7.500.000
+62.5%
0,675.000.250 USD |
7.500.000 +62.5% | 0,67 | 5.000.250 USD | |
2019-07-24 | 2019-07-22 |
Mirum Pharmaceuticals Inc
(MIRM)
|
K Kauf |
450.000
+12.0%
15,006.750.000 USD |
450.000 +12.0% | 15,00 | 6.750.000 USD | |
2019-06-28 | 2019-06-27 |
Epizyme Inc
(EPZM)
|
V Verkauf |
52.473
-100.0%
12,43652.134 USD |
52.473 -100.0% | 12,43 | 652.134 USD | |
2019-06-26 | 2019-06-26 |
Epizyme Inc
(EPZM)
|
V Verkauf |
52.472
-50.0%
12,85674.176 USD |
52.472 -50.0% | 12,85 | 674.176 USD | |
2019-06-26 | 2019-06-25 |
Epizyme Inc
(EPZM)
|
V Verkauf |
52.472
-33.3%
13,31698.649 USD |
52.472 -33.3% | 13,31 | 698.649 USD | |
2019-06-25 | 2019-06-24 |
Genocea Biosciences Inc
(GNCA)
|
K Kauf |
2.857.142
+65.4%
3,509.999.997 USD |
2.857.142 +65.4% | 3,50 | 9.999.997 USD | |
2019-05-13 | 2019-05-09 |
Trevi Therapeutics Inc
(TRVI)
|
K Kauf |
1.500.000
+51.0%
10,0015.000.000 USD |
1.500.000 +51.0% | 10,00 | 15.000.000 USD | |
2019-05-13 | 2019-05-09 |
Trevi Therapeutics Inc
(TRVI)
|
K Kauf |
1.000.000
+51.6%
10,0010.000.000 USD |
1.000.000 +51.6% | 10,00 | 10.000.000 USD | |
2019-05-09 | 2019-05-07 |
Regulus Therapeutics Inc
(RGLS)
|
K Kauf |
1.136.704
+124.1%
1,081.227.640 USD |
1.136.704 +124.1% | 1,08 | 1.227.640 USD | |
2019-04-08 | 2019-04-08 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
4.347.827
+20.8%
1,144.956.523 USD |
4.347.827 +20.8% | 1,14 | 4.956.523 USD | |
2019-03-06 | 2019-03-05 |
Mersana Therapeutics Inc
(MRSN)
|
K Kauf |
3.750.000
+46.1%
4,0015.000.000 USD |
3.750.000 +46.1% | 4,00 | 15.000.000 USD | |
2019-02-19 | 2019-02-14 |
Genocea Biosciences Inc
(GNCA)
|
K Kauf |
9.948.269
+39.8%
0,474.688.619 USD |
9.948.269 +39.8% | 0,47 | 4.688.619 USD | |
2018-12-21 | 2018-12-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
300.000
+1.5%
1,49448.380 USD |
300.000 +1.5% | 1,49 | 448.380 USD | |
2018-12-21 | 2018-12-20 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
200.000
+1.0%
1,63326.060 USD |
200.000 +1.0% | 1,63 | 326.060 USD | |
2018-12-12 | 2018-12-11 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
61.200
+0.3%
1,98121.084 USD |
61.200 +0.3% | 1,98 | 121.084 USD | |
2018-12-10 | 2018-12-10 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
26.000
+0.1%
1,9851.576 USD |
26.000 +0.1% | 1,98 | 51.576 USD | |
2018-12-10 | 2018-12-07 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
117.100
+0.6%
1,98232.362 USD |
117.100 +0.6% | 1,98 | 232.362 USD | |
2018-12-10 | 2018-12-06 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
27.300
+0.1%
1,9954.414 USD |
27.300 +0.1% | 1,99 | 54.414 USD | |
2018-11-30 | 2018-11-30 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
71.900
+0.4%
1,98142.067 USD |
71.900 +0.4% | 1,98 | 142.067 USD | |
2018-11-30 | 2018-11-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
24.500
+0.1%
1,9948.824 USD |
24.500 +0.1% | 1,99 | 48.824 USD | |
2018-11-21 | 2018-11-20 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
170.000
+0.9%
1,98336.107 USD |
170.000 +0.9% | 1,98 | 336.107 USD | |
2018-11-19 | 2018-11-19 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
510.000
+2.6%
1,88956.658 USD |
510.000 +2.6% | 1,88 | 956.658 USD | |
2018-11-19 | 2018-11-16 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
350.000
+1.8%
1,86649.355 USD |
350.000 +1.8% | 1,86 | 649.355 USD | |
2018-11-19 | 2018-11-15 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
340.000
+1.8%
1,86631.958 USD |
340.000 +1.8% | 1,86 | 631.958 USD | |
2018-08-22 | 2018-08-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
663.716
+3.7%
2,261.499.998 USD |
663.716 +3.7% | 2,26 | 1.499.998 USD | |
2018-07-20 | 2018-07-19 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
50.600
+0.3%
2,00101.165 USD |
50.600 +0.3% | 2,00 | 101.165 USD | |
2018-07-20 | 2018-07-18 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
200.000
+1.1%
1,95390.580 USD |
200.000 +1.1% | 1,95 | 390.580 USD | |
2018-06-28 | 2018-06-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
187.130
+1.1%
2,10392.692 USD |
187.130 +1.1% | 2,10 | 392.692 USD | |
2018-06-28 | 2018-06-27 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
5.295
+0.0%
2,1511.384 USD |
5.295 +0.0% | 2,15 | 11.384 USD | |
2018-05-30 | 2018-05-30 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
275
+0.0%
2,15591 USD |
275 +0.0% | 2,15 | 591 USD | |
2018-05-21 | 2018-05-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
32.200
+0.2%
2,1469.059 USD |
32.200 +0.2% | 2,14 | 69.059 USD | |
2018-05-21 | 2018-05-18 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
20.100
+0.1%
2,1442.928 USD |
20.100 +0.1% | 2,14 | 42.928 USD | |
2018-05-21 | 2018-05-17 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
184.179
+1.1%
2,13391.436 USD |
184.179 +1.1% | 2,13 | 391.436 USD | |
2018-05-10 | 2018-05-08 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
70.873
+0.4%
2,13151.250 USD |
70.873 +0.4% | 2,13 | 151.250 USD | |
2018-04-10 | 2018-04-10 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
203.200
+1.2%
2,46499.994 USD |
203.200 +1.2% | 2,46 | 499.994 USD | |
2018-04-10 | 2018-04-09 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
32.100
+0.2%
2,4378.099 USD |
32.100 +0.2% | 2,43 | 78.099 USD | |
2018-04-10 | 2018-04-06 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
685.676
+4.2%
2,241.536.943 USD |
685.676 +4.2% | 2,24 | 1.536.943 USD | |
2017-03-29 | 2017-03-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
K Kauf |
6.000.000
+57.9%
0,503.000.000 USD |
6.000.000 +57.9% | 0,50 | 3.000.000 USD |